Author

Laure Bidou

Centre National de la Recherche ScientifiqueORCID 0000-0002-3973-4058Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Olivier NamyiD· 2 shared Alexandre HinzpeteriD· 1 shared Aurélie HattoniD· 1 shared Camille Rullaud· 1 shared Claudia SerotiD· 1 shared David CornuiD· 1 shared Egor Chirkin· 1 shared Elise Dréanot· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Olivier NamyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyJournal of Cystic FibrosisPeer-reviewedAug 3, 2024

TLN468 changes the pattern of tRNA used to readthrough premature termination codons in CFTR

Sabrina Karri, David Cornu, Claudia Serot…·Olivier Namy

This study shows TLN468 promotes specific amino acid incorporation at CFTR PTCs, leading to functional CFTR variants, while gentamicin does not significantly alter amino acid proportions.

8 citations

humanexperimental assay

Molecular BiologybioRxivPreprintNov 9, 2021

2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases

Laure Bidou, Olivier Bugaud, Goulven Merer…·Olivier Namy

This study identifies 2-guanidino-quinazoline as a potent readthrough inducer for nonsense mutations, showing greater efficiency and broader sequence coverage than gentamicin.

2 citations

humanexperimental assay